Philip Morris International has pulled back yet again on disappointing guidance, but another factor may be playing a role in ...
While the top- and bottom-line numbers for Neurocrine (NBIX) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback